|
|
|
Publications 2009
|
-
Ahmad ST, Sweeney ST, Lee J-A, Sweeney NT, Gao F-B. (2009) A genetic screen identifies Serpin5 as a regulator of the Toll pathway and CHMP2B toxicity associated with frontotemporal dementia. Proc. Nat. Acad. Sci. USA. 106:12168–12173.
-
Cheng JS, Dubal DB, Kim DH, Legleiter J, Cheng IH, Yu G.-Q, Tesseur I, Wyss-Coray T, Bonaldo P, Mucke L (2009) Collagen VI protects neurons against Aβ toxicity. Nat. Neurosci. 12:119–121.
-
Cisse M and Mucke L (2009) Alzheimer's disease: A prion protein connection. Nature 457:1090–1091.
-
Daub A, Sharma P, Finkbeiner S. High content screening in primary neurons. Curr. Opin. Neurobiol. In press.
-
Friedman B, Schachtrup C, Tsai PS, Shih AY, Akassoglou K, Kleinfeld D, Lyden PD (2009) Acute vascular disruption and aquaporin 4 loss after stroke. Stroke 40:2182–2190.
-
Gaultier A, Wu X, Le Moan N, Takimoto S, Mukandala S, Akassoglou K, Campana MW, Gonias SL (2009) Low Density Lipoprotein Receptor-related Protein-1 is an essential receptor for myelin phagocytosis. J. Cell Sci. 122:1155–1162.
-
Giorgini F, Muchowski PJ (2009) Exploiting yeast genetics to inform therapeutic strategies for Huntington's disease. Methods Mol. Biol. 548:161–174.
-
Hatters DM, Voss JC, Budamagunta MS, Newhouse YN, Weisgraber KH (2009) Insight on the molecular envelope of lipid-bound apolipoprotein E from electron paramagnetic resonance spectroscopy. J. Mol. Biol. 386:261–271.
-
Khachaturian ZS, Snyder PJ, Doody R, Aisen P, Comer M, Dwyer J, Frank RA, Holzapfel A, Khachaturian AS, Korczyn AD, Roses A, Simpkins JW, Schneider LS, Albert MS, Egge R, Deves A, Ferris S, Greenberg BD, Johnson C, Kukull WA, Poirier J, Schenk D, Thies W, Gauthier S, Gilman S, Bernick C, Cummings JL, Fillit H, Grundman M, Kaye J, Mucke L, Reisberg B, Sano M, Pickeral O, Petersen RC, Mohs RC, Carrillo M, Corey-Bloom JP, Foster NL, Jacobsen S, Lee V, Potter WZ, Sabbagh MN, Salmon D, Trojanowski JQ, Wexler N, Bain LJ (2009) A roadmap for the prevention of dementia II: Leon Thal Symposium 2008. Alzheimer's Dement. 5:85–92.
-
Kreitzer AC (2009) Physiology and pharmacology of striatal neurons. Annu. Rev. Neurosci. 32:127–147.
-
Lee J-A, Gao F-B (2009) ESCRT, autophagy, and frontotemporal dementia. BMB Reports 41:827–832.
-
Lee J-A, Gao F-B. (2009) Inhibition of autophagy induction delays neuronal cell loss caused by dysfunctional ESCRT-III in frontotemporal dementia. J. Neurosci. 29:8506–8511.
-
Lee J-A, Liu L, Gao F-B. (2009) Autophagy defects contribute to dysfunctional ESCRT-III-induced neurodegeneration. Autophagy 5:1070–1072.
-
Legleiter J, Lotz GP, Miller J, Ko J, Ng C, Williams GL, Finkbeiner S, Patterson PH, Muchowski PJ (2009) Monoclonal antibodies recognize distinct conformational epitopes formed by polyglutamine in a mutant huntingtin fragment. J. Biol. Chem. 284:21647–21658.
-
Lu Y, Ferris J, Gao F-B. (2009) Frontotemporal dementia and amyotrophic lateral sclerosis-associated disease protein TDP-43 promotes dendritic branching. Mol. Brain 2:30.
-
Lu Y*, Wang F*, Li Y*, Ferris J, Lee J-A, Gao FB (2009) The Drosophila homologue of the Angelman syndrome ubiquitin ligase regulates the formation of terminal dendritic branches. Hum. Mol. Genet. 18:454–462.
-
Mahley RW, Weisgraber KH, Huang Y. (2009) Apolipoprotein E: Structure determines function—from atherosclerosis to Alzheimer's disease to AIDS. J. Lipid Res. 50:S183–S188.
-
Meilandt WJ, Cisse M, Ho K, Wu T, Esposito LA, Scearce Levie K, Cheng IH, Yu G.-Q, Mucke L (2009) Neprilysin overexpression inhibits plaque formation but fails to reduce pathogenic Aβ oligomers and associated cognitive deficits in human amyloid precursor protein transgenic mice. J. Neurosci. 29:1977–1989.
-
Miller J, Rutenber E, Muchowski PJ (2009) Polyglutamine dances the conformational cha-cha-cha. Structure 17:1151–1153.
-
Mitra S, Tsvetkov AS , Finkbeiner S. Protein turnover and inclusion body formation. Autophagy In press.
-
Mitra S, Tsvetkov A, Finkbeiner S (2009) Single neuron ubiquitin-proteasome dynamics accompanying inclusion body formation in Huntington's disease. J. Biol. Chem. 284:4398–4403.
-
Montie HL, Cho MS, Holder L, Liu Y, Tsvetkov AS , Finkbeiner S, Merry DE (2009) Cytoplasmic retention of polyglutamine-expanded androgen receptor ameliorates disease via autophagy in a mouse model of spinal and bulbar muscular atrophy. Hum. Mol. Genet. 18:1937–1950.
-
Muccioli GG, Sia A, Muchowski PJ, Stella N (2009) Genetic manipulation of palmitoylethanolamide production and inactivation in Saccharomyces cerevisiae. PLoS One 4(6):e5942.
-
Mucke L (2009) Neuroscience:Alzheimer's disease. Nature 461(7266):895–897.
-
Newhouse Y, Weisgraber KH. Apolipoprotein E expression and purification. Chapter in Methods in Molecular Biology, Humana Press In press.
-
Palop JJ and Mucke L (2009) Epilepsy and cognitive impairments in Alzheimer's disease. Arch. Neurol. 66:435–440.
-
Palop, JJ and Mucke L. Synaptic depression and aberrant excitatory network activity in Alzheimer's Disease: Two faces of the same coin? NeuroMolecular Med. In press.
-
Pintchovski SA, Peebles CL, Kim HJ, Verdin E, Finkbeiner S (2009) The serum response factor and a putative novel transcription factor regulate expression of the immediate-early gene Arc/Arg3.1 in neurons.J. Neurosci. 29:1525–1537.
-
Ryu JK, Davalos D, Akassoglou K (2009) Fibrinogen signal transduction in the nervous system. J. Thromb. Haemost. 7 Suppl 1:151–154.
-
Sun B, Halabisky B, Zhou Y, Yu G, Mucke L, Gan L. Imbalance between GABAergic and glutamatergic transmission impairs adult neurogenesis in an animal model of Alzheimer's disease. Cell Stem Cell In press.
-
Tesseur I, Zhang H, Brecht W, Corn J, Gong J.-Sheng, Yanagisawa K, Michikawa M, Weisgraber K, Huang Y, Wyss-Coray T. (2009) Bioactive TGF- β can associate with lipoproteins and is enriched in those containing apolipoprotein E3. J. Neurochemistry 110:1254–1262.
-
Tsvetkov A, Wong J, Rao V, Finkbeiner S. Differential regulation of autophagy in neuronal and non-neuronal cells. Autophagy In press.
-
Zhong N, Ramaswamy G, Weisgraber KH. (2009) Apolipoprotein E4 domain interaction induces endoplasmic reticulum stress and impairs astrocyte function. J. Biol. Chem. 284:27273–27280.
-
Zhong N, Weisgraber KH (2009) Understanding the association of apoE4 with Alzheimer's disease. Clues from its structure. J. Biol. Chem. 284:6027–6031.
- Zhong N, Weisgraber KH. Understanding the basis for the association of apoE4 with Alzheimer's disease: Opening the door for therapeutic approaches. Current Alzheimer Research. Supp. 9th International Conference on Alzheimer's Drug Discovery.(Epub ahead of print)
Top of the Page
|
|
|
|
|
|